DIUXF.US Diaceutics PLC

Healthcare Biotechnology USA Stocks
2.31 USD
Close of Nov 14, 2026
1.37 2.31
Market cap
USD 196M
P/E
-
P/B
3.79x
ROE
-28.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is DIUXF.US undervalued?

Graham number

The Graham number of Diaceutics PLC cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Diaceutics PLC fundamental analysis

No fundamental analysis for Diaceutics PLC yet.

Diaceutics PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Diaceutics PLC

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, that enables potential therapy eligibility for patients within hours of a diagnostic ev…

Full company profile